In addition, it is important to note that a recent report by Fondevila et al. (102) showed that the expression of the LPI receptor GPR55 is increased in human and mouse models of NAFLD/NASH, and that LPI lipids can promote hepatic steatosis in a GPR55-dependent manner. Here, GPR55 is linked to metabolic dysfunction-associated steatohepatitis.